China National Pharmaceutical Group Corporation (000028.SZ) reported a net profit attributable to shareholders of 606 million yuan in the first half of the year, a decrease of 8.97% compared to the same period last year.

Zhitong Finance APP reported that China National Pharmaceutical Group Corporation (000028.SZ) released its performance report for the first half of 2026. During this period, the company achieved operating revenue of 36.266 billion yuan, a year-on-year decrease of 1.44%; operating profit of 834 million yuan, a year-on-year decrease of 9.94%; total profit of 827 million yuan, a year-on-year decrease of 9.88%; and a net profit attributable to shareholders of the listed company of 606 million yuan, a year-on-year decrease of 8.97%. The corresponding basic earnings per share saw a year-on-year decrease of 9.17%. Compared to the first quarter, the decline in revenue and profit showed a narrowing trend, while the weighted average return on net assets decreased by 0.49 percentage points year-on-year.